@article {139, title = {Analysis of Antimicrobial Medication Consumption in Intensive Care Unit, North West (Tabuk) Region Hospitals, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {August 2019}, pages = {119-123}, type = {Research Article}, chapter = {119}, abstract = {

Objectives: This article describes antimicrobial medication use among different age groups and the cost associated with it in intensive care units at North West (Tabuk) hospitals, Saudi Arabia. The aim of this study to explore the antimicrobial medication use in intensive care units at North West Region Hospitals, Ministry of Health, Saudi Arabia. Methods: It is a 12-month antimicrobial drug use by intensive care units at North West region hospitals which included critical care for adults, pediatrics and neonates. The medications selected by Central Antibiotics committee at MOH as part of the National Antimicrobial Stewardship program. The consumption was driven from pharmacy database and calculated based on off standard unit of antimicrobials per hospital. The antimicrobials consisted of antibacterial drugs, antifungal and antiviral medications. The cost of antimicrobial consumption was calculated by using the Ministry of Health National Cost database. All cost used were as US currency. Results: The total number of antimicrobial standard units were (14,305) and average (2,861) per hospital. The highest drug consumption was Ceftriaxone 1 gm injection (2724) followed by Imipenem 500 mg injection (1251) and Vancomycin 500 injection (1165). The total cost of Antimicrobial consumption was (53,884.95 USD) and (10,777 USD) per each hospital. The highest cost medication consumption from Adults critical care 73.42\% (39,562.33 USD) followed by pediatrics critical care 18.15\% (9,779.93 USD) and Neonates critical care 8.43\% (4,542.68 USD). The highest medication cost was very broad-spectrum antibiotics like Meropenem, Imipenem and Ceftriaxone. It consumed more than 50\% of the cost burden. Conclusion: This study is the first in Saudi Arabia, Gulf and Middle East countries. Health system pharmacist leaders are targeting to implement the antimicrobial stewardship program and National Drug Utilization Evaluation system to control unnecessary medication expenditure and prevent misuse of medicines.

}, keywords = {Knowledge, Medications, Ministry of Health, Patient, Saudi Arabia}, doi = {10.5530/PTB.2019.5.22}, author = {Yousef Ahmed Alomi and Abeer Hussin Almasoudi and Ghormallah Abdullah Alghamdi and Samira Ali Asiri} } @article {110, title = {National Survey of Medication Safety Practice: Patient Information at Primary Healthcare Centers/Community Pharmacies in Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {4}, year = {2018}, month = {September 2018}, pages = {43-48}, type = {Research Article}, chapter = {43}, abstract = {

Objective: To explore patient{\textquoteright}s information regarding national medication safety Practice At Primary Healthcare Centers (PHCs) and Community Pharmacies (CPs) in Riyadh city, Kingdom of Saudi Arabia. Methods: This is a 4-month cross-sectional survey conducted on medication safety practice at PHCs and CPs in Riyadh city. In this study, the survey was adapted and modified from the Institution of Safe Medication Practice (ISMP) medication safety self-assessment for community/ambulatory pharmacy. It consists of a demographic section and 10 domains with 198 questions. The domains captured the following information: patient information; drug information; communication of drug orders and other drug information; drug labeling, packaging and nomenclature; use of medical devices; environmental factors; staff competency and education; patient education; quality processes; and risk management domain. The survey was conducted at the PHCs of the Ministry of Health and at CPs located in Riyadh city. This study is focused on the first domain, that is, patient information in PHCs and CPs in Riyadh city. Results: The survey was distributed to 13 PHCs and 23 CPs. The average {\textpm} Standard Deviation (SD) of all ISMP-self assessment items of medication safety practice at PHCs was 2.75{\textpm}0.36 (54.94 \%) (95\% confidence interval (95\% CI) = 2.55{\textendash}2.95; P\<0.05; range = 2.04{\textendash}3.38). The average {\textpm} SD score of all ISMP-self assessment items of medication safety practice at CPs was 3.14{\textpm}0.42 (62.86\%) (95\% CI = 2.90{\textendash}4.38; P\<0.05; range = 2.40{\textendash}.88). The average {\textpm} SD score of patient information at PHCs was 2.80{\textpm}0.467 (56 \%) (95\% CI = 2.54{\textendash}3.58; P\<0.05; range = 2.08{\textendash}3.45), whereas that of the CPs was 2.60{\textpm}0.667 (52 \%) (95\% CI = 2.23{\textendash}2.97; P\<0.05; range = 1.36{\textendash}3.96). Conclusion: The PHCs and PCs implemented almost half the of ISMP medication safety critical elements including the patient information related issue. Targeting to improve medication safety system at PHCs and CPs is highly recommended in the Kingdom of Saudi Arabia

}, keywords = {Community Pharmacy, Information, Medication, Patient, Primary Healthcare Center, Riyadh, Safety, Saudi Arabia.}, doi = {10.5530/PTB.2018.4.14}, author = {Yousef Ahmed Alomi and Rana Mohammed Alslim and Manar Mohammed Alslim and Khulud Abdulrahman Alamoudi and Zainab Abdulmunem Almuallem and Adel Mehmas H. Alragas} }